USPTO 2015–2025 USPTO PatentsView US Corporation

Omniome, Inc.

USPTO PatentsView assignee record - 36 granted patents across 9 technology areas, recorded in grant years 2018–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

RSS updates for this company

The verdict

According to USPTO PatentsView, Omniome ranks #8,888 of 49,997 tracked US assignees by granted-patent volume, with 36 patents across 9 technology areas.

#8,888
of 49,997 US assignees by volume
Top 42%
by Innovation Score (37.9/100)
23.5
avg claims per patent
+100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8888 · US Corporation #8,888 · 36 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 36 grants
  • UPPER-Q #8,888/49,997
  • PHOTO-FINISH Neocific
  • CPC-NARROW C12Q · 9 areas
  • INNOV-THIN 37.9/100
  • CLAIMS-DENSE 23.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Neocific, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Omniome’s 37.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Omniome

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Omniome's Innovation Score is 37.9/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Omniome?

Each dot is one of Omniome’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Omniome’s own 23.5 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Omniome vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 35.936.036.03636.036.036.1 10152025 Granted patents (volume) Avg claims / patent Neocific, Inc. - 36, 16.39NeocificNile Global, Inc. - 36, 16.53Nile GlobalNordex Energy GmbH - 36, 12.72Nordex EnergyOledworks GMBH - 36, 14.36OledworksOracle Financial Services Software Limited - 36, 18.86Oracle Financial…Oversec, UAB - 36, 19.56Oversec UABPactiv LLC - 36, 13.69PactivPergo (EUROPE) AB - 36, 14.08Pergo (Europe) ABOmniome, Inc. - 36, 23.53Omniome
Omniome vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Omniome's grants concentrate

Omniome, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 97.2% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2020 (11 grants) versus a trough of 3 in 2022. By volume, Omniome sits between Neocific, Inc. and Pergo (EUROPE) AB.

Omniome's three-year grant acceleration

From 2019–2021 to 2022–2024, Omniome, Inc. moved from 29 to 3 grants (0.10x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Omniome's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Omniome holds 36 patents at rank #8,887, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Omniome

By rank, the assignees closest to #8,887 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Omniome's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Omniome, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Omniome ranks #130 of 2,502 assignees by patent count in that subclass.

Omniome's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

24681012 20182019202020212022 3
USPTO utility patent grants by year · 2018–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Omniome, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 4 11.1%
2019 8 22.2%
2020 11 30.6%
2021 10 27.8%
2022 3 8.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Omniome, Inc.'s patent record in context - here's where to go next.

  • Omniome, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 97.2% of its portfolio - see every assignee active in that class. Explore C12Q
  • Ranked #8,888 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Omniome, Inc. against Neocific, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.